Untersuchung zur Wirkstoffliberation nystatinhaltiger Pasten = Libération du principe actif de la nystatine-pommade = Drug release from nystatin ointmentFALKER, G; EFFENDY, I; GÖTHEL, D et al.Aktuelle Dermatologie. 1987, Vol 13, Num 3, pp 84-87, issn 0340-2541Article

Design of novel antifungal mucoadhesive films. Part II. Formulation and in vitro biopharmaceutical evaluationLLABOT, J. M; PALMA, S. D; MANZO, R. H et al.International journal of pharmaceutics. 2007, Vol 336, Num 2, pp 263-268, issn 0378-5173, 6 p.Article

The use of nystatin to restore the flow properties of time-expired stored erythrocytesTURNER, S; WILLIAMS, A. R; REES, J. M. H et al.Vox sanguinis (Basel. 1956). 1987, Vol 52, Num 3, pp 182-185, issn 0042-9007Article

Unnecessary addition of ethylenediamine hydrochloride to generic nystatin creamsFISHER, A. A.Journal of the American Academy of Dermatology. 1989, Vol 20, Num 1, pp 129-130, issn 0190-9622Article

Particularités de mutants de la souche D2 de Candida tropicalis, resistants à la nystatine, la levorine et l'amphotericine B. I. Caractérisation phénotypique des mutants et fréquence d'induction en fonction de la qualité des lipides intracellulairesDANILENKO, I. I; BARSHTEJN, YU. A.Genetika. 1986, Vol 22, Num 2, pp 336-338, issn 0016-6758Article

Analysis and functional expression of NPP pathway-specific regulatory genes in Pseudonocardia autotrophicaJEON, Ho-Geun; SEO, Jiyoon; LEE, Mi-Jin et al.Journal of industrial microbiology & biotechnology. 2011, Vol 38, Num 4, pp 573-579, issn 1367-5435, 7 p.Article

DYNAMIQUE DE LA COPRECIPITATION DE LA NYSTATINE AVEC LA POLYVINYLPYRROLIDONEVAJNSHTEJN VA; NAUMCHIK GN.1972; ANTIBIOTIKI; S.S.S.R.; DA. 1972; VOL. 17; NO 8; PP. 750-756; BIBL. 8REF.Serial Issue

Evaluation of the post-antifungal effect (PAFE) of amphotericin B and nystatin against 30 zygomycetes using two different mediaVITALE, Roxana G; MEIS, Jacques F. G. M; MOUTON, Johan W et al.Journal of antimicrobial chemotherapy (Print). 2003, Vol 52, Num 1, pp 65-70, issn 0305-7453, 6 p.Article

Résistance de la levure aux antibiotiques polyènes. IV. Etude de l'altération héréditaire du taux de stérol due à la mutation du caractère de résistance à la nystatine chez Saccharomyces cerevisiaeMIKHAJLOVA, N. P; RODINA, L. V; LEVCHENKO, A. B et al.Genetika. 1985, Vol 21, Num 7, pp 1111-1115, issn 0016-6758Article

THE HYPOLIPEMIANT AND HYPOCHOLESTEROLEMIANT ACTION OF NYSTATIN AND CM MYSTATINAGRIGOROAEI G; AGRIGOROAEI S; SAUCIUC A et al.1980; REV. ROUMAINE BIOL., BIOL. ANIMALE; ROM; DA. 1980; VOL. 25; NO 2; PP. 155-160; BIBL. 22 REF.Article

CANDIDAMYCOSE - CONSEQUENCE DES THERAPIES AUX STEROIDES ET ANTIBIOTIQUESYAROMENKA SA; KORSUN UF; YAROMENKA VB et al.1972; VESCI AKAD. NAVUK B.S.S.R., BIJAL. NAVUK; S.S.S.R.; DA. 1972; NO 5; PP. 94-99; ABS. RUSSE; BIBL. 48REF.Serial Issue

NYSTATIN INCREASES HEPATIC ALKALINE PHOSPHATASE ACTIVITYWILFRED G; DHAYAKANI SELVAKUMAR.1983; BIOCHIMICA ET BIOPHYSICA ACTA; ISSN 0006-3002; NLD; DA. 1983; VOL. 758; NO 2; PP. 191-193; BIBL. 14 REF.Article

Résistance de la levure aux antibiotiques polyéniques. III. Analyse des phénotypes de mutants stérol résistants aux antibiotiques polyéniques de Saccharomyces cerevisiaeRODINA, L. V; LEVCHENKO, A. B; MIKHAJLOVA, N. P et al.Genetika. 1984, Vol 20, Num 7, pp 1094-1098, issn 0016-6758Article

Linkage analysis of nystatin resistance mutations in Dictyostelium discoideumWELKER, D. L.Genetics. 1986, Vol 113, Num 1, pp 53-62, issn 0016-6731Article

TOXICITY OF NYSTATIN AND ITS METHYL ESTER TOWARD PARENTAL AND HYBRID MAMMALIAN CELLS.FISHER PB; BRYSON V.1977; IN VITRO; U.S.A.; DA. 1977; VOL. 13; NO 9; PP. 548-556; BIBL. 1 P. 1/2Article

UN NOUVEL ANTIMYCOSIQUE LOCAL EN DERMATOLOGIE.ANDRIEU PFAHL F; BONNETBLANC JM; MERAUD JP et al.1977; GAZ. MED. FR.; FR.; DA. 1977; VOL. 84; NO 2; PP. 160-162Article

TRAITEMENT DES EPIDERMOMYCOSES CUTANEES D'ORIGINE MIXTE PAR NYSPORIL.BEUREY J; WEBER M; RAYMOND A et al.1976; GAZ. MED. FR.; FR.; DA. 1976; VOL. 83; NO 28; PP. 2735-2736Article

ETUDE DES CONDITIONS DU TRANSFERT DE MASSE DANS LA BIOSYNTHESE DE LA NYSTATINELOPATNEV SV; BYLINKINA ES; KLEJNER GI et al.1975; ANTIBIOTIKI; S.S.S.R.; DA. 1975; VOL. 20; NO 1; PP. 31-36; ABS. ANGL.; BIBL. 10 REF.Article

APPLICATION OF ORTHOGONAL FUNCTIONS TO DETERMINATION OF NYSTATIN IN THE PRESENCE OF ITS DEGRADATION PRODUCTSAMER MM; WAHBI AM; HABEEB et al.1975; J. PHARM. PHARMACOL.; G.B.; DA. 1975; VOL. 27; NO 5; PP. 377-378; BIBL. 5 REF.Article

THE EFFECT OF PH AND OF TEMPERATURE ON THE STABILITY AND BIOACTIVITY OF NYSTATIN AND AMPHOTERICIN BHAMILTON MILLER JMT.1973; J. PHARM. PHARMACOL.; G.B.; DA. 1973; VOL. 25; NO 5; PP. 401-407; BIBL. 20 REF.Serial Issue

ETUDE DU METABOLISME DU CARBONE CHEZ ACTINOMYCES NOURSEI PRODUCTEUR DE NYSTATINE1972; MIKROBIOLOGIJA; S.S.S.R.; DA. 1972; VOL. 41; NO 4; PP. 668-671; ABS. ANGL.; BIBL. 6REF.Serial Issue

Pharmacokinetics, tissue distribution and immunomodulatory effect of intralipid formulation of nystatin in miceSEMIS, Rita; NILI, Shai Shmuel; MUNITZ, Ariel et al.Journal of antimicrobial chemotherapy (Print). 2012, Vol 67, Num 7, pp 1716-1721, issn 0305-7453, 6 p.Article

Activity of an Intralipid formulation of nystatin in murine systemic candidiasisSEMIS, R; MENDLOVIC, S; POLACHECK, I et al.International journal of antimicrobial agents (Print). 2011, Vol 38, Num 4, pp 336-340, issn 0924-8579, 5 p.Article

PREVENTION OF FUNGAL PERITONITIS WITH NYSTATIN PROPHYLAXIS IN PATIENTS RECEIVING CAPD. CommentaryLYE, Wai-Choong; WONG, Ping-Nam; LO, Kin-Yee et al.Peritoneal dialysis international. 2007, Vol 27, Num 5, issn 0896-8608, 531-536, 511-513 [9 p.]Article

Safety, efficacy and pharmacokinetics of tuftsin-loaded nystatin liposomes in murine modelKHAN, Masood A; FAISAL, S. M; MOHAMMAD, Owais et al.Journal of drug targeting. 2006, Vol 14, Num 4, pp 233-241, issn 1061-186X, 9 p.Article